VACUNAS DE COMBINACION DE POLIOVIRUS INACTIVADO

VACUNAS DE COMBINACION DE POLIOVIRUS INACTIVADO

Una vacuna IPV que comprende: (a) toxoide diftérico; (b) toxoide tetánico; (c) células completas muertas de Bordetella pertussis; o dos o más componentes acelulares de pertussis (Pa) (por ejemplo toxoide de pertussis (PT), hemaglutinina filamentosa (FHA) y pertactina (PRN)), y (d) poliovirus tipo 1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DE HEMPTINNE, HERVE, DUCHENE, MICHEL, SONVEAUX, MARC, MARY, ANNE
Format: Patent
Sprache:spa
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DE HEMPTINNE, HERVE
DUCHENE, MICHEL
SONVEAUX, MARC
MARY, ANNE
description Una vacuna IPV que comprende: (a) toxoide diftérico; (b) toxoide tetánico; (c) células completas muertas de Bordetella pertussis; o dos o más componentes acelulares de pertussis (Pa) (por ejemplo toxoide de pertussis (PT), hemaglutinina filamentosa (FHA) y pertactina (PRN)), y (d) poliovirus tipo 1 inactivado en una dosis superior a 10 unidades de antígeno D e inferior a 20 unidades de antígeno D, en la que la vacuna está sustancialmente libre de tiomersal. The standard dose of polio vaccines contains 40 D-antigen units of inactivated poliovirus type 1 (Mahoney), 8 D-antigen units of inactivated poliovirus type 2 (MEF-1), and 32 D-antigens units of inactivated poliovirus type 3 (Saukett). The present invention teaches that reduced doses of inactivated poliovirus can maintain an adequate or improved level of protection against polio.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2365557TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2365557TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2365557TT33</originalsourceid><addsrcrecordid>eNrjZNAPc3QO9XMMVnBxVXD293Xy9HN09vT3A3ED_H08_cM8g0KDFUCiIZ5hji7-PAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3jXYyNjM1NTUPCTE2JgYNQAMpSZ9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VACUNAS DE COMBINACION DE POLIOVIRUS INACTIVADO</title><source>esp@cenet</source><creator>DE HEMPTINNE, HERVE ; DUCHENE, MICHEL ; SONVEAUX, MARC ; MARY, ANNE</creator><creatorcontrib>DE HEMPTINNE, HERVE ; DUCHENE, MICHEL ; SONVEAUX, MARC ; MARY, ANNE</creatorcontrib><description>Una vacuna IPV que comprende: (a) toxoide diftérico; (b) toxoide tetánico; (c) células completas muertas de Bordetella pertussis; o dos o más componentes acelulares de pertussis (Pa) (por ejemplo toxoide de pertussis (PT), hemaglutinina filamentosa (FHA) y pertactina (PRN)), y (d) poliovirus tipo 1 inactivado en una dosis superior a 10 unidades de antígeno D e inferior a 20 unidades de antígeno D, en la que la vacuna está sustancialmente libre de tiomersal. The standard dose of polio vaccines contains 40 D-antigen units of inactivated poliovirus type 1 (Mahoney), 8 D-antigen units of inactivated poliovirus type 2 (MEF-1), and 32 D-antigens units of inactivated poliovirus type 3 (Saukett). The present invention teaches that reduced doses of inactivated poliovirus can maintain an adequate or improved level of protection against polio.</description><language>spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20111006&amp;DB=EPODOC&amp;CC=ES&amp;NR=2365557T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20111006&amp;DB=EPODOC&amp;CC=ES&amp;NR=2365557T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DE HEMPTINNE, HERVE</creatorcontrib><creatorcontrib>DUCHENE, MICHEL</creatorcontrib><creatorcontrib>SONVEAUX, MARC</creatorcontrib><creatorcontrib>MARY, ANNE</creatorcontrib><title>VACUNAS DE COMBINACION DE POLIOVIRUS INACTIVADO</title><description>Una vacuna IPV que comprende: (a) toxoide diftérico; (b) toxoide tetánico; (c) células completas muertas de Bordetella pertussis; o dos o más componentes acelulares de pertussis (Pa) (por ejemplo toxoide de pertussis (PT), hemaglutinina filamentosa (FHA) y pertactina (PRN)), y (d) poliovirus tipo 1 inactivado en una dosis superior a 10 unidades de antígeno D e inferior a 20 unidades de antígeno D, en la que la vacuna está sustancialmente libre de tiomersal. The standard dose of polio vaccines contains 40 D-antigen units of inactivated poliovirus type 1 (Mahoney), 8 D-antigen units of inactivated poliovirus type 2 (MEF-1), and 32 D-antigens units of inactivated poliovirus type 3 (Saukett). The present invention teaches that reduced doses of inactivated poliovirus can maintain an adequate or improved level of protection against polio.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAPc3QO9XMMVnBxVXD293Xy9HN09vT3A3ED_H08_cM8g0KDFUCiIZ5hji7-PAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3jXYyNjM1NTUPCTE2JgYNQAMpSZ9</recordid><startdate>20111006</startdate><enddate>20111006</enddate><creator>DE HEMPTINNE, HERVE</creator><creator>DUCHENE, MICHEL</creator><creator>SONVEAUX, MARC</creator><creator>MARY, ANNE</creator><scope>EVB</scope></search><sort><creationdate>20111006</creationdate><title>VACUNAS DE COMBINACION DE POLIOVIRUS INACTIVADO</title><author>DE HEMPTINNE, HERVE ; DUCHENE, MICHEL ; SONVEAUX, MARC ; MARY, ANNE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2365557TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2011</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>DE HEMPTINNE, HERVE</creatorcontrib><creatorcontrib>DUCHENE, MICHEL</creatorcontrib><creatorcontrib>SONVEAUX, MARC</creatorcontrib><creatorcontrib>MARY, ANNE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DE HEMPTINNE, HERVE</au><au>DUCHENE, MICHEL</au><au>SONVEAUX, MARC</au><au>MARY, ANNE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VACUNAS DE COMBINACION DE POLIOVIRUS INACTIVADO</title><date>2011-10-06</date><risdate>2011</risdate><abstract>Una vacuna IPV que comprende: (a) toxoide diftérico; (b) toxoide tetánico; (c) células completas muertas de Bordetella pertussis; o dos o más componentes acelulares de pertussis (Pa) (por ejemplo toxoide de pertussis (PT), hemaglutinina filamentosa (FHA) y pertactina (PRN)), y (d) poliovirus tipo 1 inactivado en una dosis superior a 10 unidades de antígeno D e inferior a 20 unidades de antígeno D, en la que la vacuna está sustancialmente libre de tiomersal. The standard dose of polio vaccines contains 40 D-antigen units of inactivated poliovirus type 1 (Mahoney), 8 D-antigen units of inactivated poliovirus type 2 (MEF-1), and 32 D-antigens units of inactivated poliovirus type 3 (Saukett). The present invention teaches that reduced doses of inactivated poliovirus can maintain an adequate or improved level of protection against polio.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language spa
recordid cdi_epo_espacenet_ES2365557TT3
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title VACUNAS DE COMBINACION DE POLIOVIRUS INACTIVADO
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T04%3A19%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DE%20HEMPTINNE,%20HERVE&rft.date=2011-10-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2365557TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true